FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128164062> ?p ?o ?g. }

• W3128164062 endingPage "1204" @default.
• W3128164062 startingPage "1189" @default.
• W3128164062 abstract "Sinomenine has been known to inhibit the proliferation of breast cancer cells. However, its targets have not been found yet. This study aimed to search for molecular targets of sinomenine for treating breast cancer via network pharmacology.Potential targets of sinomenine or breast cancer were separately screened from indicated databases. The common targets of both sinomenine and breast cancer were considered as the targets of sinomenine for treating breast cancer. A sinomenine-target-pathway network was constructed based on the obtained results from Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. The putative targets of sinomenine were further determined by using protein-protein interaction (PPI) analysis and molecular docking. Finally, the putative targets were verified in vitro and in vivo.Twenty predicted targets were identified through network pharmacological analysis. Gene Ontology (GO) and KEGG pathway enrichment indicated that these predicted targets enriched in the process of MAP kinase activity, VEGF signaling pathway, Relaxin signaling pathway, Growth hormone synthesis, secretion and action. MAPK1, NOS3, NR3C1, NOS1 and NOS2 were further identified as the putative targets by using PPI and molecular docking analysis. Expression of MAPK1, NR3C1, NOS1, NOS2 and NOS3 genes were significantly regulated by sinomenine in both MCF-7 cells and MDA-MB-231 cells. Furthermore, the expression of NR3C1 in human breast cancer specimens was lower than that in para-tumor normal tissues. Meanwhile, the expression of NR3C1 in xenograft tumors was up-regulated after sinomenine treatment.MAPK1, NR3C1, NOS1, NOS2 and NOS3 were identified as the putative targets of sinomenine for treating breast cancer. NR3C1 was preliminarily confirmed as a target of sinomenine in two breast cancer cell lines, xenograft tumor models and human breast cancer specimens. These data indicated that the network pharmacology-based prediction of sinomenine targets for treating breast cancer could be reliable." @default.
• W3128164062 created "2021-02-15" @default.
• W3128164062 creator A5003374733 @default.
• W3128164062 creator A5007009918 @default.
• W3128164062 creator A5031845006 @default.
• W3128164062 creator A5033870092 @default.
• W3128164062 creator A5034538718 @default.
• W3128164062 creator A5053513964 @default.
• W3128164062 creator A5070457968 @default.
• W3128164062 creator A5073178667 @default.
• W3128164062 creator A5077391806 @default.
• W3128164062 creator A5079477222 @default.
• W3128164062 date "2021-02-01" @default.
• W3128164062 modified "2023-10-02" @default.
• W3128164062 title "Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer" @default.
• W3128164062 cites W1490956705 @default.
• W3128164062 cites W1495375466 @default.
• W3128164062 cites W1850351657 @default.
• W3128164062 cites W1917948530 @default.
• W3128164062 cites W1968826816 @default.
• W3128164062 cites W1994893641 @default.
• W3128164062 cites W2023926251 @default.
• W3128164062 cites W2033591223 @default.
• W3128164062 cites W2033975364 @default.
• W3128164062 cites W2035618305 @default.
• W3128164062 cites W2036681504 @default.
• W3128164062 cites W2047963812 @default.
• W3128164062 cites W2048739031 @default.
• W3128164062 cites W2050153313 @default.
• W3128164062 cites W2074473216 @default.
• W3128164062 cites W2095233432 @default.
• W3128164062 cites W2130761695 @default.
• W3128164062 cites W2134898801 @default.
• W3128164062 cites W2134967712 @default.
• W3128164062 cites W2141240574 @default.
• W3128164062 cites W2149200346 @default.
• W3128164062 cites W2156893819 @default.
• W3128164062 cites W2159675211 @default.
• W3128164062 cites W2218151226 @default.
• W3128164062 cites W2275620121 @default.
• W3128164062 cites W2309323726 @default.
• W3128164062 cites W2410805430 @default.
• W3128164062 cites W2412845632 @default.
• W3128164062 cites W2510876230 @default.
• W3128164062 cites W2577915723 @default.
• W3128164062 cites W2604536255 @default.
• W3128164062 cites W2606625830 @default.
• W3128164062 cites W2607129810 @default.
• W3128164062 cites W2755766923 @default.
• W3128164062 cites W2767110894 @default.
• W3128164062 cites W2781490082 @default.
• W3128164062 cites W2781749016 @default.
• W3128164062 cites W2795201991 @default.
• W3128164062 cites W2802221918 @default.
• W3128164062 cites W2804044371 @default.
• W3128164062 cites W2806692854 @default.
• W3128164062 cites W2889646458 @default.
• W3128164062 cites W2890656124 @default.
• W3128164062 cites W2897651816 @default.
• W3128164062 cites W2900569176 @default.
• W3128164062 cites W2906015203 @default.
• W3128164062 cites W2917075888 @default.
• W3128164062 cites W2934505158 @default.
• W3128164062 cites W2962828868 @default.
• W3128164062 cites W2965229774 @default.
• W3128164062 cites W2975243836 @default.
• W3128164062 cites W2976761080 @default.
• W3128164062 cites W2990350731 @default.
• W3128164062 cites W3024432685 @default.
• W3128164062 cites W3049642946 @default.
• W3128164062 cites W4237095724 @default.
• W3128164062 doi "https://doi.org/10.2147/cmar.s282684" @default.
• W3128164062 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7881794" @default.
• W3128164062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33603465" @default.
• W3128164062 hasPublicationYear "2021" @default.
• W3128164062 type Work @default.
• W3128164062 sameAs 3128164062 @default.
• W3128164062 citedByCount "9" @default.
• W3128164062 countsByYear W31281640622022 @default.
• W3128164062 countsByYear W31281640622023 @default.
• W3128164062 crossrefType "journal-article" @default.
• W3128164062 hasAuthorship W3128164062A5003374733 @default.
• W3128164062 hasAuthorship W3128164062A5007009918 @default.
• W3128164062 hasAuthorship W3128164062A5031845006 @default.
• W3128164062 hasAuthorship W3128164062A5033870092 @default.
• W3128164062 hasAuthorship W3128164062A5034538718 @default.
• W3128164062 hasAuthorship W3128164062A5053513964 @default.
• W3128164062 hasAuthorship W3128164062A5070457968 @default.
• W3128164062 hasAuthorship W3128164062A5073178667 @default.
• W3128164062 hasAuthorship W3128164062A5077391806 @default.
• W3128164062 hasAuthorship W3128164062A5079477222 @default.
• W3128164062 hasBestOaLocation W31281640621 @default.
• W3128164062 hasConcept C104317684 @default.
• W3128164062 hasConcept C121608353 @default.
• W3128164062 hasConcept C150194340 @default.
• W3128164062 hasConcept C152724338 @default.
• W3128164062 hasConcept C162317418 @default.
• W3128164062 hasConcept C2777662524 @default.

• next